CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.43
52W Range
$0.40 - $98.60
50D Avg
$0.67
200D Avg
$6.08
Market Cap
$3.51M
Avg Vol (3M)
$2.00M
Beta
0.68
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.